Cargando…
Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645268/ http://dx.doi.org/10.1186/2051-1426-3-S2-P141 |
| _version_ | 1782400796636217344 |
|---|---|
| author | Agrawal, Shruti Feng, Yan Roy, Amit Kollia, Georgia Lestini, Brian |
| author_facet | Agrawal, Shruti Feng, Yan Roy, Amit Kollia, Georgia Lestini, Brian |
| author_sort | Agrawal, Shruti |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645268 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46452682015-11-20 Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy Agrawal, Shruti Feng, Yan Roy, Amit Kollia, Georgia Lestini, Brian J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645268/ http://dx.doi.org/10.1186/2051-1426-3-S2-P141 Text en Copyright © 2015 Agrawal et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Agrawal, Shruti Feng, Yan Roy, Amit Kollia, Georgia Lestini, Brian Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy |
| title | Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy |
| title_full | Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy |
| title_fullStr | Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy |
| title_full_unstemmed | Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy |
| title_short | Nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy |
| title_sort | nivolumab dose selection: challenges, opportunities and lessons learned for cancer immunotherapy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645268/ http://dx.doi.org/10.1186/2051-1426-3-S2-P141 |
| work_keys_str_mv | AT agrawalshruti nivolumabdoseselectionchallengesopportunitiesandlessonslearnedforcancerimmunotherapy AT fengyan nivolumabdoseselectionchallengesopportunitiesandlessonslearnedforcancerimmunotherapy AT royamit nivolumabdoseselectionchallengesopportunitiesandlessonslearnedforcancerimmunotherapy AT kolliageorgia nivolumabdoseselectionchallengesopportunitiesandlessonslearnedforcancerimmunotherapy AT lestinibrian nivolumabdoseselectionchallengesopportunitiesandlessonslearnedforcancerimmunotherapy |